Evidence map›Paper›PMID 31537194›Full record

Trial reportStroke2019

Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.

Adam de Havenon, Nora F Fino, Brian Johnson, Ka-Ho Wong, Jennifer J Majersik, David Tirschwell, Natalia Rost

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Stroke, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Asian expert consensus on high-quality hypertension management.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Simultaneous measurement of coronary sinus flow and myocardial flow reserve using hybridThe international journal of cardiovascular imaging · 2025
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adam de HavenonFrom the Department of Neurology (A.d.H., B.J., K.-H.W., J.J.M.), University of Utah, Salt Lake City.
Nora F FinoDivision of Epidemiology, Department of Internal Medicine (N.F.F.), University of Utah, Salt Lake City.
Brian JohnsonFrom the Department of Neurology (A.d.H., B.J., K.-H.W., J.J.M.), University of Utah, Salt Lake City.
Ka-Ho WongFrom the Department of Neurology (A.d.H., B.J., K.-H.W., J.J.M.), University of Utah, Salt Lake City.
Jennifer J MajersikFrom the Department of Neurology (A.d.H., B.J., K.-H.W., J.J.M.), University of Utah, Salt Lake City.
David TirschwellDepartment of Neurology, University of Washington, Seattle (D.T.).
Natalia RostDepartment of Neurology, Massachusetts General Hospital, Boston (N.R.).

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
MRI-GENetics Interface Exploration_MRI-GENIE_StudyR01NS086905 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2015 to 2019
$3.3M
UT StrokeNet Administrative SupplementU24NS107228 · NINDS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jennifer Juhl Majersik · 2018 to 2026
$3.0M
Statins augment small vessel function and improve stroke outcomesR01NS082285 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2013 to 2017
$2.6M
Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRIK23NS105924 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2019 to 2023
$988k
NCATS NIH HHS UL1 TR002538NINDS NIH HHS K23 NS105924NINDS NIH HHS R01 NS082285NINDS NIH HHS R01 NS086905NINDS NIH HHS U24 NS107228
6 · The paper itself

Abstract

Background and Purpose- Every year in the United States, almost 185 000 ischemic strokes occur in patients with a prior stroke. Recurrent stroke has significantly higher morbidity and mortality. Among modifiable risk factors for recurrent stroke, hypertension is the most prevalent. Reducing systolic blood pressure is standard of care for secondary stroke prevention. Recent literature suggests that increased blood pressure variability (BPV) is associated with primary stroke, although studies have not convincingly shown that it is associated with recurrent stroke, which was the goal of this analysis. Methods- We conducted a secondary analysis of 17 916 patients in the PRoFESS (Prevention Regimen for Effectively Avoiding Second Strokes) trial, which is the largest trial of patients with potential recurrent stroke. We calculated BPV and evaluated its effect on recurrent stroke (composite and stratified by ischemic or hemorrhagic stroke), major cardiovascular events (death from cardiovascular causes, recurrent stroke, myocardial infarction, or new or worsening heart failure), and all-cause death. Results- Both systolic and diastolic BPV were associated with recurrent stroke, major cardiovascular events, and all-cause death. The association with stroke was significant for ischemic, but not hemorrhagic, stroke. For every 10-point increase in BPV (systolic SD, range =0-54.2), the hazard ratio for a recurrent ischemic stroke was 1.15 (95% CI, 1.02-1.32;

Indexed as

Blood PressureHeart FailureHypertensionIntracranial HemorrhagesMyocardial InfarctionStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedRisk Factorsblood pressureheart failurehypertensionmyocardial infarctionrenal insufficiency

Identifiers

PMID31537194
PMCPMC6817411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.